SCHEMBL2037211

SCHEMBL2037211

O=[N+]([O-])c1cccc(OCN2CCOCC2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.51
CHRNA4 P43681 2/20 0.51
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51
LTA4H P09960 1/20 0.50
PTGS2 P35354 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MGLL Q99685 1/20 0.50
ALDH1A1 P00352 4/20 0.49
CTSB P07858 1/20 0.49
MAPT P10636 2/20 0.48
LMNA P02545 1/20 0.48
KCNJ1 P48048 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
PHGDH O43175 1/20 0.46
POLB P06746 1/20 0.46
FAAH O00519 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29848488 0.87 LTA4H (0.67) CHRNB2CHRNA4CHRNB4CHRNA3LTA4H
SCHEMBL1961763 0.87 LTA4H (0.67) CHRNB2CHRNA4CHRNB4CHRNA3LTA4H
SCHEMBL13949514 0.86 CYP1A2 (0.59) CHRNB2CHRNA4LTA4HPTGS2KDM4E
SCHEMBL2635694 0.80 FKBP1A (0.66) KDM4EMGLLALDH1A1MAPTSMN1; SMN2
SCHEMBL30560053 0.76 ALDH1A1 (0.67) KDM4EALDH1A1CTSBMAPTLMNA
SCHEMBL357155 0.76 ALDH1A1 (0.67) KDM4EALDH1A1CTSBMAPTLMNA
SCHEMBL4562977 0.76 SMN1; SMN2 (0.50) KDM4EALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL3168151 0.76 KDM4E (0.64) KDM4EALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL4599121 0.75 ALDH1A1 (0.65) KDM4EMGLLALDH1A1MAPTSMN1; SMN2
SCHEMBL255055 0.74 ESR1 (0.58) LTA4HKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2327677-A1 Mono-nitration of aromatic compounds F. Hoffmann-La Roche AG (CH) 2011-06-01 EP disclosed
EP-2016034-A2 MONO-NITRATION OF AROMATIC COMPOUNDS F. Hoffmann-Roche AG (CH) 2009-01-21 EP disclosed
US-7429589-B2 Mono-nitration of aromatic compounds via nitrate salts HOFFMANN-LA ROCHE INC. (US) 2008-09-30 US disclosed
WO-2007125034-A2 MONO-NITRATION OF AROMATIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2007-11-08 WO disclosed
US-20070255057-A1 Mono-nitration of aromatic compounds via nitrate salts CEDILOTE MIALL 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255057-A1 Mono-nitration of aromatic compounds via nitrate salts NOS2, NOS3, NOS1 CHRNB2 667/4885CHRNA4 1104/4885CHRNB4 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.